AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pasithea Therapeutics Corp. Director's Dealing 2022

Aug 15, 2022

35389_dirs_2022-08-15_3d6139c6-9424-4bf0-8de0-6ba6e514791b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pasithea Therapeutics Corp. (KTTA)
CIK: 0001841330
Period of Report: 2022-08-09

Reporting Person: Geller Avi (10% Owner, Member of 10% owner group)
Reporting Person: Leonite Capital LLC (10% Owner, Member of 10% owner group)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1034702	Indirect

Footnotes

F1: The shares are held by Leonite Capital LLC, of which Avi Geller serves as Chief Investment Officer.